protein 587 words KG: LDLRPROTEIN
Contents

LDLR Protein (Low-Density Lipoprotein Receptor)

🔬 Protein Info
Gene SymbolLDLR
AliasesLDLRPROTEIN
Chromosome19p13.2
Protein TypeReceptor
Target ClassReceptor
FunctionLDL Binding: Extracellular domain binds circulating LDL (containing cholesterol and triglycerides)
Mechanism of ActionUpregulation through PCSK9 inhibition or direct receptor modulation
DruggabilityHigh (0.75)
Clinical StageApproved
Amino Acids860 aa
Exons18
PathwaysCholesterol, Cholesterol Metabolism, Complement, EGFR_signaling, Endocytosis
UniProt IDH0YMD1
Ensembl IDENSG00000130164
GeneCardsLDLR
Human Protein AtlasLDLR
Associated DiseasesADH, Aging, Als, Alzheimer
Known Drugs/Compounds25-Hydroxycholesterol, lipid_lowering_medications, statins
InteractionsAB, ABCA1, abca2, ABCA2, ACETYL-COA, Actin
SciDEX TargetView Target Profile (8 clinical trials)
SciDEX HypothesesFcRn Transport Bypass Strategy
LRP1-Mediated Endosomal Escape Enhancement Strateg
LDLR-Targeted Anti-Inflammatory Antibody Delivery (+6 more)
KG Connections1224 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

UniProtWikipedia

Related Hypotheses (17)

Cholesterol-CRISPR Convergence Therapy for Neurodegeneration
Score: 0.62
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
APOE Isoform Conversion Therapy
Score: 0.72
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Membrane Cholesterol Gradient Modulators
Score: 0.71
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.86
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
Magnetosonic-Triggered Transferrin Receptor Clustering
Score: 0.72
Reelin-Mediated Cytoskeletal Stabilization Protocol
Score: 0.69
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.62
Serine/Arginine-Rich Protein Kinase Modulation
Score: 0.62
Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m
Score: 0.62

Related Analyses (11)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived

Related Experiments (3)

AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40

See Also (15)

Neurodegeneration
disease · KG edge: implicated_in
LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 5 hypotheses
ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT
clinical · Pages share 5 hypotheses
Extracellular Vesicle and Tunneling Nanotube-Mediated S
mechanism · Pages share 5 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 5 hypotheses

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.